Let's Get Started

Environment

Could Canoo (GOEV) Be The Next TESLA??

Could Canoo (GOEV) Be The Next TESLA??

Nov 24, 2021

Company Snapshot:

Company Name: Canoo Inc. 

Ticker: GOEV

Exchange: NASDAQ

Website: www.canoo.com

Industry: 

Company Summary: 

Canoo’s mission is to bring EVs to Everyone. The company has developed breakthrough electric vehicles that are reinventing the automotive landscape with bold innovations in design, pioneering technologies, and a unique business model that spans the full lifecycle of the vehicle. Distinguished by its experienced team from leading technology and automotive companies – Canoo has designed a modular electric platform purpose-built to deliver maximum vehicle interior space that is customizable across all owners in the vehicle lifecycle to support a wide range of vehicle applications for consumers and businesses. Canoo has offices in California and Texas.

Canoo’s charts look incredible: 

The 1 day chart above reveals resistance at $12.50 PPS, so make sure it’s clear of it before entering a position Friday.

As you can see from the 6 month chart above, we have hit a 6 month high with 100% gains in 14 weeks, so nice and steady!

UPDATE: Investors invested in GOEV, that’s putting your money where your mouth is!

NASDAQ reports “Over the last year, we can see that the biggest insider purchase was by insider Daniel Hennessy for US$5.0m worth of shares, at about US$10.00 per share.”

Why is it up 100% over the last 14 weeks?

This company is REAL and making serious moves! 

In Arkansas Business, they state, “Electric automaker Canoo Inc. announced late Monday that it will move its headquarters to northwest Arkansas, pledging to employ more than 500 people in Benton and Washington counties.”

There is another EV manufacturer you may have heard of, Tesla, current share price of $1,116 per share!

So you have a EV manufacturer making good on manufacturing plants and the possibility that it could be 10% of Tesla and BOOM , $111 per share price up $100+/- from today’s price! That is wealth and there is attention being paid with this gem.

Summary

We like this stock! Fundamentals are good and technicals are solid as well. $5M of shares purchased at $10 is also really good because it is undervalued at $12 so there is lots of room for a nice long term play, 

Happy trading!

read more
3 STOCKS, 3 Stories and 3 Takeaways: ISPC, ASTR & PRVB!

3 STOCKS, 3 Stories and 3 Takeaways: ISPC, ASTR & PRVB!

Nov 23, 2021

A tale of three stocks, a tale as old as time: ISPC, ASTR & PRVB

Company Snapshot

Company Name: iSpecimen

Ticker: ISPC

Exchange: NASDAQ

Website: www.ispecimen.com

Industry  Medical

Company Summary:

iSpecimen offers an online marketplace for human biospecimens, connecting life scientists in commercial and non-profit organizations with healthcare providers that have access to patients and specimens needed for medical discovery. Proprietary, cloud-based technology enables scientists to intuitively search for specimens and patients across a federated partner network of hospitals, labs, biobanks, blood centers, and other healthcare organizations. 

Why did it go up over 100%?

iSpecimen announced yesterday that it has been contracted to support new advanced research on COVID-19 seeking insights on its transmissibility, variants, outcomes, and testing validity among multiple population segments. In the last ten months, the company has partnered with multiple research and health care organizations on a range of diverse projects requiring a variety of COVID-19 samples, including nasal swabs, saliva, and blood products.

1 Day Chart 

Technical Analysis

There was a mad rush to buy this stock after the news that iSpecimen had been contracted to support new advanced research on COVID-19 seeking insights on its transmissibility, variants, outcomes, and testing validity among multiple population segments. Anything related to Covid is going crazy simply because it has impacted our lives so significantly that we are overly interested in solutions to this worldwide pandemic. 

So, my technical analysis of this Covid stock is, it was overbought hence the pull back after the premarket buy up. The correction was significant at $11.64 to an intraday low of $8.12 accounting for a 30% retrace. It broke out of the bullish trend at the end of the day, but it could be a head fake. Be careful and make sure to get a solid confirmation before thinking about this purchase. 

Company Snapshot

Company Name: Astra Space, Inc.

Ticker: ASTR

Exchange: NASDAQ

Website: www.astra.com 

Company Summary:

Astra’s mission is to improve life on Earth from space by creating a healthier and more connected planet. Today, Astra offers the one of the lowest cost-per-launch dedicated orbital launch service of any operational launch provider in the world. Astra completed its first commercial orbital launch in November 2021, making it one of the fastest U.S. company in history to reach this milestone. Astra is based in Alameda, California, and was founded in 2016. 

Why did it go up over 50%?

Astra Space successfully completed its first commercial orbital launch for the United States Space Force late Friday night, November 19, 2021, PST. The launch, STP-27AD2, was conducted from Astra’s Kodiak Spaceport, located at the Pacific Spaceport Complex in Kodiak, Alaska. 

1 Month Chart 

5 Day Chart 

Technical Analysis

Again, this is a very popular subject since Tesla, Elon Musk and Space X became the talk of the world after reaching space! So, what does the market do upon the big news, they buy this stock up in a mad frenzy in response. Our advice is the same as iSpecimen, wait for a solid confirmation of a breakout. We are looking for a consolidation and a breakout, keep an eye on it!

Company Snapshot

Company Name: Provention Bio

Ticker: PRVB

Exchange: Nasdaq

Website: www.proventionbio.com

Industry BioMedical

Company Summary:

Provention Bio, Inc. is a biopharmaceutical company focused on advancing the development of investigational therapies that may intercept and prevent debilitating and life-threatening immune-mediated disease. The Company’s pipeline includes clinical-stage product candidates that have demonstrated in pre-clinical or clinical studies proof-of-mechanism and/or proof-of-concept in autoimmune diseases, including type 1 diabetes, celiac disease and lupus.

Why did it go up over 15%?

Provention Bio had a Type A meeting with the FDA to discuss the population pharmacokinetic (popPK) model to be used for the purpose of planned commercial and clinical drug product comparison. In preliminary meeting comments, the FDA approved the Company proceeding to populate the popPK model with data collected from patients receiving therapeutic doses of teplizumab in a pharmacokinetic/pharmacodynamic (PK/PD) substudy of the ongoing PROTECT Phase 3 trial in newly diagnosed type 1 diabetes (T1D) patients (Commercial Product N~30 patients, Clinical Drug Product N~130 patients).

1 Day Chart 

Technical Analysis

We think this is a reasonable market reaction to the news, it wasn’t over-purchased, it was just right! Now of course, reactions work in both directions, up and down. So even though it was a proper spike, why did it pull back, human reaction! It spikes and starts retracing and the market gets afraid. 

Summary on ISPC, ASTRA & PRVB

3 stories and three takeaways! A tale of three stocks, a tale that has been told since the inception of the stock exchanges. 

  1. Takeaway 1: What goes up (fast) must go down  – premarket huge spikes are normally a dangerous play. If you really like the stock, wait, let it pull back from the over buying and make an extra 10-50% by being patient!
  2. Takeaway 2: Traders normally over react – in a world where the all mighty dollar is the true definition of happiness and success, combined with our optimistic nature, breads an environment for the “get rich fast” idea. We all want desperately to “hit it big” that’s why Vegas is what it is. 
  3. Takeaway 3: Carefully curated news properly placed creates a massive amount of interest specially when written properly.

Happy trading and REMEMBER, never try to catch a falling safe! Let it crash to the ground and walk over and pick up the money!

read more
American Battery Metals (ABML) Stock Resumes The Uptrend: Will it Continue?

American Battery Metals (ABML) Stock Resumes The Uptrend: Will it Continue?

Jun 9, 2021

If you are currently looking into the possibility of investing in stocks that might have performed strongly over the course of the past week then you could consider the American Battery Metals Corporation (OTCMKTS:ABML) stock.

The stock was in focus yesterday as it jumped by 5% and took its gains for the month to as much as 40%. There was no fresh development with regards to American Battery Metals yesterday but it might be worthwhile to take a look at development from last week. The lithium-ion battery recycling technology company signed an escrow for a property situated at 695 E Sydney Drive in Storey County, Nevada.

The property spans across an area of 13.8 acres and is a part of the famed Tahoe Reno Industrial Park, which is widely known as the biggest industrial park in the planet. The acquisition of this parcel of land could prove to be a significant boost to the company’s business as well.

American Battery Metals is currently involved in supplying batter metals through its three separate business divisions. One of those is primary resources and the other two are from extraction technology and lithium ion battery recycling. Not too long ago, American Battery Metals had announced that the groundbreaking of its lithium ion battery recycling plant at Fernley in Nevada had also been done.

On the other hand, back in May, the company had made another announcement that could have resulted in considerable optimism among investors.

American Battery Metals announced that is submitted an application for the uplisting of its shares to the NASDAQ Stock Market. Considering the fact that Nasdaq is one of the biggest stock exchanges in the world, a possible listing could open up a world of new opportunities for the company. However, it should be noted that acceptance is not guaranteed and the company will need to meet a range of requirements before the stock can be listed.

read more
Kronos Advanced Technologies Inc. (OTCMKTS:KNOS) Stock Surges 150% in July: What’s Next?

Kronos Advanced Technologies Inc. (OTCMKTS:KNOS) Stock Surges 150% in July: What’s Next?

Jul 29, 2020

One of the more interesting companies to have emerged in recent years is that of Kronos Advanced Technologies Inc. (OTCMKTS:KNOS) and in recent times the company has made some notable moves. The company is involved in the product development and production space and is primarily known for having revolutionised the way in which air is moved, filtered and sterilized. 

Major Triggers 

Earlier this month, the company announced the launch of the 1-800-SAFE AIR Independent Sales Rep program, by way of which the company intends to sign up as many as 200 sales representatives across the United States in the third fiscal quarter.

The move from Kronos is aimed at selling a larger volume of its products through a new sales channel altogether. Kronos went for the program in response to feedback from both customers and shareholders. Kronos is going to supply the sales representatives with marketing materials, online marketing support, and also marketing videos. 

In addition to that, the sales representatives will also get incentives which include promotional items and special pricing. At this point in time, the company is considering several online portals for the purpose of recruiting new independent sales representatives. 

While the launch of this program could prove to be a long term positive, there was another important announcement from the company this month. Kronos announced last week that it has decided to transform the company into a Public Benefit Corporation. This implies that the well being of the consumers is the primary concern of the company rather than profitability. 

The Chief Transformation Officer of Kronos Advanced stated that the company wishes to become one of the few publicly traded firms which put the interests of the customers above profit. It is a major move for the company and it remains to be seen how it is going to have an effect on its operations in the months to come.

read more